Topic:

Partnering

Latest Headlines

Latest Headlines

UPDATED: FDA agrees to review Endo Pharmaceutical's inside-the-cheek pain drug

Endo Pharmaceutical's investigational Belbuca buccal film strip for severe chronic pain has been accepted for review by the FDA, marking a win for the BioErodible MucoAdhesive technology to deliver drugs across mucosal surfaces like the inside of the cheek. And BEMA platform developer BioDelivery Sciences receives a $10 million milestone payment.

UPDATED: NIH funds studies of J&J's and GSK's injectable HIV meds, says daily pills lead to noncompliance

In bid to improve patient adherence, the U.S. National Institutes of Health is funding and helping run two clinical trials of long-acting injectable HIV candidates being developed by Johnson & Johnson's Janssen and GlaxoSmithKline.

South Korea's CTC Bio out licenses drug-delivery technology to Swiss-based Ferring

South Korea's CTC Bio has out licensed rights to its drug-delivery technology to Swiss-based Ferring Pharmaceuticals, with the two companies to collaborate and develop in-vitro and in-vivo tests of drug prototypes.

Gilead plows ahead in India with Mylan deal on hep C, but will it work?

Mylan Pharmaceuticals Private has signed an agreement with Gilead Sciences for exclusive rights in India to distribute the best-selling Sovaldi (sofosbuvir) and Harvoni combination with ledipasvir for treating hepatitis C.

Nakashima, Teijin to establish JV to develop Japanese joint implants

Teijin and Nakashima Holdings are joining forces to try to claim a bigger share of the Japanese medical device market. Teijin is acquiring half of Nakashima Medical, a subsidiary of Nakashima Holdings, for about ¥1.5 billion ($12.6 million) as of April 1.

Theorem partners up for patient testing

Theorem Clinical Research has signed a deal with Biomedical Systems to expands its testing services, enlisting a partner with expertise in diagnostics.

Merck bets big on NGM with a $450M handshake

Taking a page from famed partners like Sanofi and Regeneron and Roche and Genentech, Merck has signed a sweeping R&D deal with biotech NGM Biopharmaceuticals, promising up to $450 million for 5 years of pipeline-building collaboration.

Japan biotech AnGes MG transfers local Collatagene marketing rights to Mitsubishi Tanabe

AnGes MG has formed a new partnership with Mitsubishi Tanabe Pharma Corporation for the marketing of investigational gene therapy Collategene (beperminogene perplasmid) in Japan, ending ties with Daiichi Sankyo.

China FDA draft GCP guidelines in line with harmonization aims

China FDA has issued draft guidelines on changes to good clinical practice guidelines that cover 34 provisions, including the use of outsourced partners in China that are generally in line with international aims of harmonization.

Lupin inks two partnerships to bring lung drugs to overseas markets

Indian drugmaker Lupin announced two separate developments in its asthma drug delivery segment, launching one product in the U.S. and signing a development agreement for a generic version of GlaxoSmithKline's Advair Diskus, which would be commercialized in North America and other markets.